Sustanon 250Hormone TherapySafety Rating 7/10

Primary research areaTRT

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose rangeTRT: 250 mg IM every 2–3 weeks (standard). Performance: 250–750 mg/week. Ester blend allows less frequent dosing than single short esters.
AdministrationVaries
Safety7/10 · Approved (various countries)
NCAA D1Banned

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Sustanon 250

Mechanism of action

Blend of 4 testosterone esters (propionate 30mg, phenylpropionate 60mg, isocaproate 60mg, decanoate 100mg); provides rapid onset (propionate) with sustained levels (decanoate); all convert to active testosterone.

Safety profile

Same as all testosterone: testicular atrophy, infertility, polycythemia, cardiovascular risk, acne, gynecomastia. Ester blend can cause irregular hormone fluctuations vs. single esters. · Approved TRT; well-characterized at therapeutic doses; cardiovascular monitoring; polycythemia

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Sustanon 250

Failed to fetch